Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells 30,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $13.44, for a total value of $403,200.00. Following the completion of the transaction, the president owned 2,042,899 shares in the company, valued at approximately $27,456,562.56. This represents a 1.45% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, June 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $14.48, for a total value of $434,400.00.
• On Wednesday, May 14th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $14.87, for a total transaction of $446,100.00.

Alignment Healthcare Stock Performance

ALHC traded down $0.14 during midday trading on Tuesday, reaching $13.26. The company had a trading volume of 1,815,703 shares, compared to its average volume of 2,232,961. The business has a 50-day moving average of $14.61 and a two-hundred day moving average of $15.31. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 2.95. Alignment Healthcare, Inc. has a 1 year low of $7.92 and a 1 year high of $21.06. The company has a market cap of $2.62 billion, a P/E ratio of -27.63 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.07. The company had revenue of $926.93 million for the quarter, compared to analysts' expectations of $889.83 million. Alignment Healthcare had a negative net margin of 3.02% and a negative return on equity of 80.49%. The firm's revenue was up 47.5% compared to the same quarter last year. During the same quarter last year, the business earned ($0.25) EPS. As a group, equities research analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Alignment Healthcare

Several hedge funds have recently modified their holdings of ALHC. MCF Advisors LLC raised its position in Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after purchasing an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ purchased a new stake in Alignment Healthcare during the 1st quarter valued at $42,000. Amalgamated Bank lifted its position in Alignment Healthcare by 21.6% in the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after buying an additional 616 shares during the last quarter. RiverPark Advisors LLC bought a new stake in Alignment Healthcare in the fourth quarter worth about $106,000. Finally, Tower Research Capital LLC TRC grew its stake in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after buying an additional 6,286 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have commented on ALHC. Stifel Nicolaus increased their price objective on Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a report on Tuesday, April 8th. Robert W. Baird boosted their price target on Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Finally, UBS Group boosted their price target on Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a research note on Friday, May 2nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $17.17.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.